DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Reliance Chemotex Industries Limited — Board Meeting Intimation

NSE 11 hrs ago·6 Aug 2026, 6:04 am

Reliance Industries

Reliance Chemotex Industries has announced that its board will meet on August 11, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a standard procedural update that signals the company is preparing to disclose its performance for the period.

For investors, this announcement is a key milestone as it will provide the first official glimpse into the company's operational health and financial trajectory for the first half of the fiscal year. The results will likely highlight revenue growth, profitability, and operational efficiency, helping investors assess the stock's current momentum.

Investors should watch for the release of these results to gauge the company's performance against market expectations and peer benchmarks. This data will be crucial for making informed decisions about the stock's future potential.